Kerstin Hill
Leipzig, SN, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Pharmacological modulation of TRPV2 enhances migration and induces Immunoglobulin E (IgE)-independent degranulation of mast cells.
Journal: Cell calcium
Published: March 18, 2026
Structural origins of species-specific differences in TRPV2 activation.
Journal: Nature communications
Published: March 09, 2026
Defining AV2-1 as a novel pharmacological probe to target human and rodent TRPV2.
Journal: British journal of pharmacology
Published: October 06, 2025
Activation of TRPV3 channels in bladder cancer cells stimulates ATP release.
Journal: Molecular pharmacology
Published: May 06, 2025
Physiological functions and pharmacological targeting of transient receptor potential channels.
Journal: Pharmacological reviews
Published: March 24, 2025
Pharmacological inhibition of TRPV2 attenuates phagocytosis and lipopolysaccharide-induced migration of primary macrophages.
Journal: British journal of pharmacology
Published: April 21, 2022
Pharmacological agents selectively acting on the channel moieties of TRPM6 and TRPM7.
Journal: Cell calcium
Published: April 19, 2022
KS0365, a novel activator of the transient receptor potential vanilloid 3 (TRPV3) channel, accelerates keratinocyte migration.
Journal: British journal of pharmacology
Published: October 22, 2021
Valdecoxib blocks rat TRPV2 channels.
Journal: European journal of pharmacology
Published: July 12, 2021
A benzothiadiazine derivative and methylprednisolone are novel and selective activators of transient receptor potential canonical 5 (TRPC5) channels.
Journal: Cell calcium
Published: March 10, 2017
Inflammatory pain control by blocking oxidized phospholipid-mediated TRP channel activation.
Journal: Scientific reports
Published: February 10, 2017
Last Updated: 09/26/2026